{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:34:13Z","timestamp":1794864853131,"version":"4.9.1"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41575-023-00771-6","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T06:03:17Z","timestamp":1682056997000},"page":"447-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":468,"title":["Gut\u2013liver axis: barriers and functional circuits"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-883X","authenticated-orcid":false,"given":"Oliver","family":"Pabst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Hornef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1597-572X","authenticated-orcid":false,"given":"Frank G.","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1392-0669","authenticated-orcid":false,"given":"Vuk","family":"Cerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7229-5595","authenticated-orcid":false,"given":"Thomas","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-6914","authenticated-orcid":false,"given":"Tony","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/imm.13149","volume":"159","author":"MW Hornef","year":"2020","unstructured":"Hornef, M. W. & Torow, N. \u2018Layered immunity\u2019 and the \u2018neonatal window of opportunity\u2019 \u2013 timed succession of non-redundant phases to establish mucosal host\u2013microbial homeostasis after birth. Immunology 159, 15\u201325 (2020).","journal-title":"Immunology"},{"key":"771_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02912537","volume":"17","author":"U Volta","year":"1987","unstructured":"Volta, U. et al. IgA antibodies to dietary antigens in liver cirrhosis. Ric. Clin. Lab. 17, 235\u2013242 (1987).","journal-title":"Ric. Clin. Lab."},{"key":"771_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi, A. et al. The gut\u2013liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397\u2013411 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"771_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","volume":"18","author":"J Trebicka","year":"2021","unstructured":"Trebicka, J., Bork, P., Krag, A. & Arumugam, M. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat. Rev. Gastroenterol. Hepatol. 18, 167\u2013180 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"771_CR5","doi-asserted-by":"publisher","first-page":"a029314","DOI":"10.1101\/cshperspect.a029314","volume":"10","author":"A Buckley","year":"2018","unstructured":"Buckley, A. & Turner, J. R. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb. Perspect. Biol. 10, a029314 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"771_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10620-015-3935-y","volume":"61","author":"V Volynets","year":"2016","unstructured":"Volynets, V. et al. Assessment of the intestinal barrier with five different permeability tests in healthy C57BL\/6J and BALB\/cJ mice. Dig. Dis. Sci. 61, 737\u2013746 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"771_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nm.4430","volume":"23","author":"AM Mowat","year":"2017","unstructured":"Mowat, A. M., Scott, C. L. & Bain, C. C. Barrier-tissue macrophages: functional adaptation to environmental challenges. Nat. Med. 23, 1258\u20131270 (2017).","journal-title":"Nat. Med."},{"key":"771_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41385-022-00579-8","volume":"15","author":"LC Frazer","year":"2022","unstructured":"Frazer, L. C. & Good, M. Intestinal epithelium in early life. Mucosal Immunol. 15, 1181\u20131187 (2022).","journal-title":"Mucosal Immunol."},{"key":"771_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1463","volume":"2","author":"V Muncan","year":"2011","unstructured":"Muncan, V. et al. Blimp1 regulates the transition of neonatal to adult intestinal epithelium. Nat. Commun. 2, 452 (2011).","journal-title":"Nat. Commun."},{"key":"771_CR10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fimmu.2020.01153","volume":"11","author":"B Westrom","year":"2020","unstructured":"Westrom, B., Arevalo Sureda, E., Pierzynowska, K., Pierzynowski, S. G. & Perez-Cano, F. J. The immature gut barrier and its importance in establishing immunity in newborn mammals. Front. Immunol. 11, 1153 (2020).","journal-title":"Front. Immunol."},{"key":"771_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1113\/jphysiol.1969.sp008903","volume":"204","author":"RM Clarke","year":"1969","unstructured":"Clarke, R. M. & Hardy, R. N. An analysis of the mechanism of cessation of uptake of macromolecular substances by the intestine of the young rat (\u2018closure\u2019). J. Physiol. 204, 127\u2013134 (1969).","journal-title":"J. Physiol."},{"key":"771_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature07255","volume":"455","author":"W He","year":"2008","unstructured":"He, W. et al. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 455, 542\u2013546 (2008).","journal-title":"Nature"},{"key":"771_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-1898-4","volume":"577","author":"W Zheng","year":"2020","unstructured":"Zheng, W. et al. Microbiota-targeted maternal antibodies protect neonates from enteric infection. Nature 577, 543\u2013548 (2020).","journal-title":"Nature"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"eabh3816","DOI":"10.1126\/sciimmunol.abh3816","volume":"7","author":"KZ Sanidad","year":"2022","unstructured":"Sanidad, K. Z. et al. Maternal gut microbiome-induced IgG regulates neonatal gut microbiome and immunity. Sci. Immunol. 7, eabh3816 (2022).","journal-title":"Sci. Immunol."},{"key":"771_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164775","volume":"11","author":"E Arevalo Sureda","year":"2016","unstructured":"Arevalo Sureda, E., Westrom, B., Pierzynowski, S. G. & Prykhodko, O. Maturation of the intestinal epithelial barrier in neonatal rats coincides with decreased FcRn expression, replacement of vacuolated enterocytes and changed Blimp-1 expression. PLoS ONE 11, e0164775 (2016).","journal-title":"PLoS ONE"},{"key":"771_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.aad2571","volume":"351","author":"M Gomez de Aguero","year":"2016","unstructured":"Gomez de Aguero, M. et al. The maternal microbiota drives early postnatal innate immune development. Science 351, 1296\u20131302 (2016).","journal-title":"Science"},{"key":"771_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.devcel.2019.08.001","volume":"51","author":"J Park","year":"2019","unstructured":"Park, J. et al. Lysosome-rich enterocytes mediate protein absorption in the vertebrate gut. Dev. Cell 51, 7\u201320.e6 (2019).","journal-title":"Dev. Cell"},{"key":"771_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004833","volume":"10","author":"NN Remis","year":"2014","unstructured":"Remis, N. N. et al. Mucolipin co-deficiency causes accelerated endolysosomal vacuolation of enterocytes and failure-to-thrive from birth to weaning. PLoS Genet. 10, e1004833 (2014).","journal-title":"PLoS Genet."},{"key":"771_CR19","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s00431-021-04102-2","volume":"180","author":"S Kolyva","year":"2021","unstructured":"Kolyva, S., Triga, M., Kritikou, D. & Chrysis, D. The effect of feeding patterns on serum zonulin levels in infants at 3-4 months of age. Eur. J. Pediatr. 180, 3273\u20133278 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"771_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3112","volume":"12","author":"H Renz","year":"2011","unstructured":"Renz, H., Brandtzaeg, P. & Hornef, M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 12, 9\u201323 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"771_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41232-018-0072-y","volume":"38","author":"Y Nakamura","year":"2018","unstructured":"Nakamura, Y., Kimura, S. & Hase, K. M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance. Inflamm. Regen. 38, 15 (2018).","journal-title":"Inflamm. Regen."},{"key":"771_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67292","volume":"10","author":"JK Gustafsson","year":"2021","unstructured":"Gustafsson, J. K. et al. Intestinal goblet cells sample and deliver lumenal antigens by regulated endocytic uptake and transcytosis. Elife 10, e67292 (2021).","journal-title":"Elife"},{"key":"771_CR23","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1084\/jem.20160770","volume":"214","author":"T Jinnohara","year":"2017","unstructured":"Jinnohara, T. et al. IL-22BP dictates characteristics of Peyer\u2019s patch follicle-associated epithelium for antigen uptake. J. Exp. Med. 214, 1607\u20131618 (2017).","journal-title":"J. Exp. Med."},{"key":"771_CR24","doi-asserted-by":"publisher","first-page":"15064","DOI":"10.1073\/pnas.0803124105","volume":"105","author":"ME Johansson","year":"2008","unstructured":"Johansson, M. E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA 105, 15064\u201315069 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2021.07.014","volume":"73","author":"DA Constant","year":"2021","unstructured":"Constant, D. A., Nice, T. J. & Rauch, I. Innate immune sensing by epithelial barriers. Curr. Opin. Immunol. 73, 1\u20138 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"771_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1209791","volume":"334","author":"S Vaishnava","year":"2011","unstructured":"Vaishnava, S. et al. The antibacterial lectin RegIII\u03b3 promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255\u2013258 (2011).","journal-title":"Science"},{"key":"771_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/mi.2015.32","volume":"8","author":"GM Birchenough","year":"2015","unstructured":"Birchenough, G. M., Johansson, M. E., Gustafsson, J. K., Bergstrom, J. H. & Hansson, G. C. New developments in goblet cell mucus secretion and function. Mucosal Immunol. 8, 712\u2013719 (2015).","journal-title":"Mucosal Immunol."},{"key":"771_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.chom.2014.07.001","volume":"16","author":"ME Sellin","year":"2014","unstructured":"Sellin, M. E. et al. Epithelium-intrinsic NAIP\/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16, 237\u2013248 (2014).","journal-title":"Cell Host Microbe"},{"key":"771_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-018-0395-5","volume":"560","author":"M Fulde","year":"2018","unstructured":"Fulde, M. et al. Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition. Nature 560, 489\u2013493 (2018).","journal-title":"Nature"},{"key":"771_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.immuni.2019.02.014","volume":"50","author":"Z Al Nabhani","year":"2019","unstructured":"Al Nabhani, Z. et al. A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity 50, 1276\u20131288.e5 (2019).","journal-title":"Immunity"},{"key":"771_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","volume":"43","author":"TC Scharschmidt","year":"2015","unstructured":"Scharschmidt, T. C. et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43, 1011\u20131021 (2015).","journal-title":"Immunity"},{"key":"771_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41586-021-04044-7","volume":"599","author":"IC Boothby","year":"2021","unstructured":"Boothby, I. C. et al. Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin. Nature 599, 667\u2013672 (2021).","journal-title":"Nature"},{"key":"771_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-020-2977-2","volume":"589","author":"A Gola","year":"2021","unstructured":"Gola, A. et al. Commensal-driven immune zonation of the liver promotes host defence. Nature 589, 131\u2013136 (2021).","journal-title":"Nature"},{"key":"771_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41423-019-0246-9","volume":"17","author":"M Li","year":"2020","unstructured":"Li, M. et al. A wave of Foxp3(+) regulatory T cell accumulation in the neonatal liver plays unique roles in maintaining self-tolerance. Cell Mol. Immunol. 17, 507\u2013518 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"771_CR35","doi-asserted-by":"publisher","first-page":"279736","DOI":"10.1155\/2014\/279736","volume":"2014","author":"A Maria","year":"2014","unstructured":"Maria, A., English, K. A. & Gorham, J. D. Appropriate development of the liver Treg compartment is modulated by the microbiota and requires TGF-\u03b2 and MyD88. J. Immunol. Res. 2014, 279736 (2014).","journal-title":"J. Immunol. Res."},{"key":"771_CR36","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg, H., Adolph, T. E. & Trauner, M. Gut\u2013liver axis: pathophysiological concepts and clinical implications. Cell Metab. 34, 1700\u20131718 (2022).","journal-title":"Cell Metab."},{"key":"771_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41385-021-00448-w","volume":"15","author":"C Luciani","year":"2022","unstructured":"Luciani, C., Hager, F. T., Cerovic, V. & Lelouard, H. Dendritic cell functions in the inductive and effector sites of intestinal immunity. Mucosal Immunol. 15, 40\u201350 (2022).","journal-title":"Mucosal Immunol."},{"key":"771_CR38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature07240","volume":"455","author":"K Atarashi","year":"2008","unstructured":"Atarashi, K. et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 455, 808\u2013812 (2008).","journal-title":"Nature"},{"key":"771_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2011.01.016","volume":"34","author":"U Hadis","year":"2011","unstructured":"Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34, 237\u2013246 (2011).","journal-title":"Immunity"},{"key":"771_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/mi.2015.77","volume":"9","author":"SA Houston","year":"2016","unstructured":"Houston, S. A. et al. The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct. Mucosal Immunol. 9, 468\u2013478 (2016).","journal-title":"Mucosal Immunol."},{"key":"771_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-019-1125-3","volume":"569","author":"D Esterhazy","year":"2019","unstructured":"Esterhazy, D. et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature 569, 126\u2013130 (2019).","journal-title":"Nature"},{"key":"771_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1084\/jem.20060227","volume":"203","author":"AJ Macpherson","year":"2006","unstructured":"Macpherson, A. J. & Smith, K. Mesenteric lymph nodes at the center of immune anatomy. J. Exp. Med. 203, 497\u2013500 (2006).","journal-title":"J. Exp. Med."},{"key":"771_CR43","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1084\/jem.20080039","volume":"205","author":"SI Hammerschmidt","year":"2008","unstructured":"Hammerschmidt, S. I. et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J. Exp. Med. 205, 2483\u20132490 (2008).","journal-title":"J. Exp. Med."},{"key":"771_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/mi.2013.54","volume":"7","author":"S Cording","year":"2014","unstructured":"Cording, S. et al. The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodes. Mucosal Immunol. 7, 359\u2013368 (2014).","journal-title":"Mucosal Immunol."},{"key":"771_CR45","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.immuni.2021.08.014","volume":"54","author":"M Muschaweck","year":"2021","unstructured":"Muschaweck, M. et al. Cognate recognition of microbial antigens defines constricted CD4+ T cell receptor repertoires in the inflamed colon. Immunity 54, 2565\u20132577.e6 (2021).","journal-title":"Immunity"},{"key":"771_CR46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song, X. et al. Microbial bile acid metabolites modulate gut ROR\u03b3+ regulatory T cell homeostasis. Nature 577, 410\u2013415 (2020).","journal-title":"Nature"},{"key":"771_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","volume":"13","author":"O Pabst","year":"2020","unstructured":"Pabst, O. & Slack, E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol. 13, 12\u201321 (2020).","journal-title":"Mucosal Immunol."},{"key":"771_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-03973-7","volume":"598","author":"T Rollenske","year":"2021","unstructured":"Rollenske, T. et al. Parallelism of intestinal secretory IgA shapes functional microbial fitness. Nature 598, 657\u2013661 (2021).","journal-title":"Nature"},{"key":"771_CR49","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1084\/jem.20180427","volume":"215","author":"A Nakajima","year":"2018","unstructured":"Nakajima, A. et al. IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria. J. Exp. Med. 215, 2019\u20132034 (2018).","journal-title":"J. Exp. Med."},{"key":"771_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2013.00185","volume":"4","author":"B Corthesy","year":"2013","unstructured":"Corthesy, B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front. Immunol. 4, 185 (2013).","journal-title":"Front. Immunol."},{"key":"771_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.immuni.2017.06.013","volume":"47","author":"G Magri","year":"2017","unstructured":"Magri, G. et al. Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals. Immunity 47, 118\u2013134.e8 (2017).","journal-title":"Immunity"},{"key":"771_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49923-2","volume":"9","author":"JR Catanzaro","year":"2019","unstructured":"Catanzaro, J. R. et al. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. Sci. Rep. 9, 13574 (2019).","journal-title":"Sci. Rep."},{"key":"771_CR53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","volume":"20","author":"K Chen","year":"2020","unstructured":"Chen, K., Magri, G., Grasset, E. K. & Cerutti, A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat. Rev. Immunol. 20, 427\u2013441 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"771_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2016.04.014","volume":"151","author":"L Moro-Sibilot","year":"2016","unstructured":"Moro-Sibilot, L. et al. Mouse and human liver contain immunoglobulin A-secreting cells originating from Peyer\u2019s patches and directed against intestinal antigens. Gastroenterology 151, 311\u2013323 (2016).","journal-title":"Gastroenterology"},{"key":"771_CR55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.aad0135","volume":"350","author":"I Spadoni","year":"2015","unstructured":"Spadoni, I. et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350, 830\u2013834 (2015).","journal-title":"Science"},{"key":"771_CR56","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","volume":"71","author":"J Mouries","year":"2019","unstructured":"Mouries, J. et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J. Hepatol. 71, 1216\u20131228 (2019).","journal-title":"J. Hepatol."},{"key":"771_CR57","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi, A. et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell 39, 708\u2013724.e11 (2021).","journal-title":"Cancer Cell"},{"key":"771_CR58","doi-asserted-by":"publisher","first-page":"eabe6729","DOI":"10.1126\/science.abe6729","volume":"373","author":"YH Han","year":"2021","unstructured":"Han, Y. H. et al. Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science 373, eabe6729 (2021).","journal-title":"Science"},{"key":"771_CR59","doi-asserted-by":"publisher","first-page":"237ra266","DOI":"10.1126\/scitranslmed.3008618","volume":"6","author":"ML Balmer","year":"2014","unstructured":"Balmer, M. L. et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci. Transl Med. 6, 237ra266 (2014).","journal-title":"Sci. Transl Med."},{"key":"771_CR60","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.devcel.2022.01.004","volume":"57","author":"Y Liang","year":"2022","unstructured":"Liang, Y. et al. Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics. Dev. Cell 57, 398\u2013414.e5 (2022).","journal-title":"Dev. Cell"},{"key":"771_CR61","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2021.10.015","volume":"76","author":"JI Almeida","year":"2022","unstructured":"Almeida, J. I. et al. Hallmarks of the human intestinal microbiome on liver maturation and function. J. Hepatol. 76, 694\u2013725 (2022).","journal-title":"J. Hepatol."},{"key":"771_CR62","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","volume":"54","author":"G De Simone","year":"2021","unstructured":"De Simone, G. et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity 54, 2089\u20132100.e8 (2021).","journal-title":"Immunity"},{"key":"771_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.018","author":"M Guilliams","year":"2022","unstructured":"Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell https:\/\/doi.org\/10.1016\/j.cell.2021.12.018 (2022).","journal-title":"Cell"},{"key":"771_CR64","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel, J. et al. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity 51, 638\u2013654.e9 (2019).","journal-title":"Immunity"},{"key":"771_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep43985","volume":"7","author":"J Volckmar","year":"2017","unstructured":"Volckmar, J. et al. Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver. Sci. Rep. 7, 43985 (2017).","journal-title":"Sci. Rep."},{"key":"771_CR66","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/gutjnl-2020-323771","volume":"71","author":"BG Wiggins","year":"2022","unstructured":"Wiggins, B. G. et al. The human liver microenvironment shapes the homing and function of CD4+ T-cell populations. Gut 71, 1399\u20131411 (2022).","journal-title":"Gut"},{"key":"771_CR67","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek, M. et al. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature 592, 444\u2013449 (2021).","journal-title":"Nature"},{"key":"771_CR68","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","volume":"27","author":"A Deczkowska","year":"2021","unstructured":"Deczkowska, A. et al. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nat. Med. 27, 1043\u20131054 (2021).","journal-title":"Nat. Med."},{"key":"771_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00663-1","author":"S Zundler","year":"2022","unstructured":"Zundler, S. et al. Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-022-00663-1 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"771_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17183-8","volume":"11","author":"N van Best","year":"2020","unstructured":"van Best, N. et al. Bile acids drive the newborn\u2019s gut microbiota maturation. Nat. Commun. 11, 3692 (2020).","journal-title":"Nat. Commun."},{"key":"771_CR71","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.immuni.2021.09.004","volume":"54","author":"BC Trindade","year":"2021","unstructured":"Trindade, B. C. et al. The cholesterol metabolite 25-hydroxycholesterol restrains the transcriptional regulator SREBP2 and limits intestinal IgA plasma cell differentiation. Immunity 54, 2273\u20132287.e6 (2021).","journal-title":"Immunity"},{"key":"771_CR72","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","volume":"48","author":"J Emgard","year":"2018","unstructured":"Emgard, J. et al. Oxysterol sensing through the receptor GPR183 promotes the lymphoid-tissue-inducing function of innate lymphoid cells and colonic inflammation. Immunity 48, 120\u2013132.e8 (2018).","journal-title":"Immunity"},{"key":"771_CR73","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-022-05546-8","volume":"613","author":"KM Kennedy","year":"2023","unstructured":"Kennedy, K. M. et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 613, 639\u2013649 (2023).","journal-title":"Nature"},{"key":"771_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2022.11.012","author":"I Lagkouvardos","year":"2022","unstructured":"Lagkouvardos, I. et al. Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants. Am. J. Clin. Nutr. https:\/\/doi.org\/10.1016\/j.ajcnut.2022.11.012 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"771_CR75","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1073\/pnas.1000081107","volume":"108","author":"JE Koenig","year":"2011","unstructured":"Koenig, J. E. et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl Acad. Sci. USA 108, 4578\u20134585 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR76","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri.2017.58","volume":"17","author":"AJ Macpherson","year":"2017","unstructured":"Macpherson, A. J., de Aguero, M. G. & Ganal-Vonarburg, S. C. How nutrition and the maternal microbiota shape the neonatal immune system. Nat. Rev. Immunol. 17, 508\u2013517 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"771_CR77","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.01.024","volume":"158","author":"G Galazzo","year":"2020","unstructured":"Galazzo, G. et al. Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood. Gastroenterology 158, 1584\u20131596 (2020).","journal-title":"Gastroenterology"},{"key":"771_CR78","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2468-1253(20)30267-3","volume":"5","author":"LH Nguyen","year":"2020","unstructured":"Nguyen, L. H. et al. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol. Hepatol. 5, 986\u2013995 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"771_CR79","doi-asserted-by":"publisher","first-page":"100884","DOI":"10.1016\/j.eclinm.2021.100884","volume":"36","author":"M Agrawal","year":"2021","unstructured":"Agrawal, M. et al. Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses. EClinicalMedicine 36, 100884 (2021).","journal-title":"EClinicalMedicine"},{"key":"771_CR80","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcmgh.2018.05.008","volume":"6","author":"H Yoon","year":"2018","unstructured":"Yoon, H. et al. Increased pancreatic protease activity in response to antibiotics impairs gut barrier and triggers colitis. Cell Mol. Gastroenterol. Hepatol. 6, 370\u2013388.e3 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"771_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).","journal-title":"PLoS Biol."},{"key":"771_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","volume":"72","author":"H Chu","year":"2020","unstructured":"Chu, H. et al. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J. Hepatol. 72, 391\u2013400 (2020).","journal-title":"J. Hepatol."},{"key":"771_CR83","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","volume":"69","author":"S Lemoinne","year":"2020","unstructured":"Lemoinne, S. et al. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 69, 92\u2013102 (2020).","journal-title":"Gut"},{"key":"771_CR84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan, Y. et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575, 505\u2013511 (2019).","journal-title":"Nature"},{"key":"771_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","volume":"7","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y. et al. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. J. Immunother. Cancer 7, 193 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"771_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003334","volume":"9","author":"J Mao","year":"2021","unstructured":"Mao, J. et al. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J. Immunother. Cancer 9, e003334 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"771_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux, C., Marinelli, L., Blottiere, H. M., Larraufie, P. & Lapaque, N. SCFA: mechanisms and functional importance in the gut. Proc. Nutr. Soc. 80, 37\u201349 (2021).","journal-title":"Proc. Nutr. Soc."},{"key":"771_CR88","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.chom.2018.11.002","volume":"24","author":"YS Lee","year":"2018","unstructured":"Lee, Y. S. et al. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development. Cell Host Microbe 24, 833\u2013846.e6 (2018).","journal-title":"Cell Host Microbe"},{"key":"771_CR89","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","volume":"49","author":"A Metidji","year":"2018","unstructured":"Metidji, A. et al. The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity 49, 353\u2013362.e5 (2018).","journal-title":"Immunity"},{"key":"771_CR90","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","volume":"159","author":"G Sorrentino","year":"2020","unstructured":"Sorrentino, G. et al. Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration. Gastroenterology 159, 956\u2013968.e8 (2020).","journal-title":"Gastroenterology"},{"key":"771_CR91","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662\u2013671 (2015).","journal-title":"Cell Host Microbe"},{"key":"771_CR92","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2022.01.017","volume":"185","author":"I Leonardi","year":"2022","unstructured":"Leonardi, I. et al. Mucosal fungi promote gut barrier function and social behavior via type 17 immunity. Cell 185, 831\u2013846.e14 (2022).","journal-title":"Cell"},{"key":"771_CR93","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA 111, 2247\u20132252 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR94","doi-asserted-by":"publisher","first-page":"eaao4755","DOI":"10.1126\/scitranslmed.aao4755","volume":"10","author":"NA Scott","year":"2018","unstructured":"Scott, N. A. et al. Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis. Sci. Transl Med. 10, eaao4755 (2018).","journal-title":"Sci. Transl Med."},{"key":"771_CR95","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-019-0884-1","volume":"566","author":"N Morita","year":"2019","unstructured":"Morita, N. et al. GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. Nature 566, 110\u2013114 (2019).","journal-title":"Nature"},{"key":"771_CR96","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 802\u2013816 (2016).","journal-title":"Immunity"},{"key":"771_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"771_CR98","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475\u2013479 (2020).","journal-title":"Nature"},{"key":"771_CR99","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","volume":"603","author":"D Paik","year":"2022","unstructured":"Paik, D. et al. Human gut bacteria produce TH17-modulating bile acid metabolites. Nature 603, 907\u2013912 (2022).","journal-title":"Nature"},{"key":"771_CR100","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","volume":"29","author":"W Li","year":"2021","unstructured":"Li, W. et al. A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. Cell Host Microbe 29, 1366\u20131377.e9 (2021).","journal-title":"Cell Host Microbe"},{"key":"771_CR101","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585\u20131595 (2015).","journal-title":"Cell"},{"key":"771_CR102","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","volume":"20","author":"AS Devlin","year":"2016","unstructured":"Devlin, A. S. et al. Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20, 709\u2013715 (2016).","journal-title":"Cell Host Microbe"},{"key":"771_CR103","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2021","unstructured":"Costa, D. et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J. Hepatol. 74, 819\u2013828 (2021).","journal-title":"J. Hepatol."},{"key":"771_CR104","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2021","unstructured":"Arroyo, V. et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J. Hepatol. 74, 670\u2013685 (2021).","journal-title":"J. Hepatol."},{"key":"771_CR105","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan, J. et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 30, 675\u2013688.e7 (2019).","journal-title":"Cell Metab."},{"key":"771_CR106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","volume":"27","author":"B Seo","year":"2020","unstructured":"Seo, B. et al. Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host Microbe 27, 25\u201340.e6 (2020).","journal-title":"Cell Host Microbe"},{"key":"771_CR107","doi-asserted-by":"publisher","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","volume":"12","author":"L Maccioni","year":"2020","unstructured":"Maccioni, L. et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes 12, 1782157 (2020).","journal-title":"Gut Microbes"},{"key":"771_CR108","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","volume":"71","author":"M Sorribas","year":"2019","unstructured":"Sorribas, M. et al. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J. Hepatol. 71, 1126\u20131140 (2019).","journal-title":"J. Hepatol."},{"key":"771_CR109","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/gutjnl-2020-321663","volume":"71","author":"M Haderer","year":"2022","unstructured":"Haderer, M. et al. Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases. Gut 71, 580\u2013592 (2022).","journal-title":"Gut"},{"key":"771_CR110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0168-8278(91)90930-A","volume":"12","author":"JF Colombel","year":"1991","unstructured":"Colombel, J. F. et al. Jejunal immunoglobulin secretion in alcoholic patients with and without cirrhosis. J. Hepatol. 12, 145\u2013149 (1991).","journal-title":"J. Hepatol."},{"key":"771_CR111","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/gut.23.6.475","volume":"23","author":"G Pelletier","year":"1982","unstructured":"Pelletier, G., Briantais, M. J., Buffet, C., Pillot, J. & Etienne, J. P. Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut 23, 475\u2013480 (1982).","journal-title":"Gut"},{"key":"771_CR112","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/hep.24018","volume":"53","author":"AW Yan","year":"2011","unstructured":"Yan, A. W. et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96\u2013105 (2011).","journal-title":"Hepatology"},{"key":"771_CR113","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/hep.24789","volume":"55","author":"Z Teltschik","year":"2012","unstructured":"Teltschik, Z. et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 55, 1154\u20131163 (2012).","journal-title":"Hepatology"},{"key":"771_CR114","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest, R., Lawson, M. & Geuking, M. Pathological bacterial translocation in liver cirrhosis. J. Hepatol. 60, 197\u2013209 (2014).","journal-title":"J. Hepatol."},{"key":"771_CR115","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","volume":"58","author":"J Du Plessis","year":"2013","unstructured":"Du Plessis, J. et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J. Hepatol. 58, 1125\u20131132 (2013).","journal-title":"J. Hepatol."},{"key":"771_CR116","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","volume":"19","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 19, 227\u2013239 (2016).","journal-title":"Cell Host Microbe"},{"key":"771_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27385-3","volume":"12","author":"Y Duan","year":"2021","unstructured":"Duan, Y. et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat. Commun. 12, 7172 (2021).","journal-title":"Nat. Commun."},{"key":"771_CR118","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-022-04949-x","volume":"607","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Within-host evolution of a gut pathobiont facilitates liver translocation. Nature 607, 563\u2013570 (2022).","journal-title":"Nature"},{"key":"771_CR119","doi-asserted-by":"publisher","first-page":"11667","DOI":"10.1073\/pnas.1911870117","volume":"117","author":"J Luther","year":"2020","unstructured":"Luther, J. et al. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proc. Natl Acad. Sci. USA 117, 11667\u201311673 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"771_CR121","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","volume":"8","author":"D Haussinger","year":"2022","unstructured":"Haussinger, D. et al. Hepatic encephalopathy. Nat. Rev. Dis. Primers\u00a08, 43 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"771_CR122","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","volume":"115","author":"L Craven","year":"2020","unstructured":"Craven, L. et al. Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial. Am. J. Gastroenterol. 115, 1055\u20131065 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"771_CR123","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep4.1601","volume":"4","author":"JJ Witjes","year":"2020","unstructured":"Witjes, J. J. et al. Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis. Hepatol. Commun. 4, 1578\u20131590 (2020).","journal-title":"Hepatol. Commun."},{"key":"771_CR124","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913\u2013916.e7 (2012).","journal-title":"Gastroenterology"},{"key":"771_CR125","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","volume":"70","author":"JS Bajaj","year":"2019","unstructured":"Bajaj, J. S. et al. Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial. Hepatology 70, 1690\u20131703 (2019).","journal-title":"Hepatology"},{"key":"771_CR126","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj, J. S. et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology 66, 1727\u20131738 (2017).","journal-title":"Hepatology"},{"key":"771_CR127","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","volume":"37","author":"CA Philips","year":"2018","unstructured":"Philips, C. A., Phadke, N., Ganesan, K., Ranade, S. & Augustine, P. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J. Gastroenterol. 37, 215\u2013225 (2018).","journal-title":"Indian J. Gastroenterol."},{"key":"771_CR128","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","volume":"12","author":"CA Philips","year":"2022","unstructured":"Philips, C. A., Ahamed, R., Rajesh, S., Abduljaleel, J. K. P. & Augustine, P. Long-term outcomes of stool transplant in alcohol-associated hepatitis \u2013 analysis of clinical outcomes, relapse, gut microbiota and comparisons with standard care. J. Clin. Exp. Hepatol. 12, 1124\u20131132 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"771_CR129","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","volume":"16","author":"A Sharma","year":"2022","unstructured":"Sharma, A. et al. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol. Int. 16, 433\u2013446 (2022).","journal-title":"Hepatol. Int."},{"key":"771_CR130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","volume":"53","author":"C Marcella","year":"2021","unstructured":"Marcella, C. et al. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment. Pharmacol. Ther. 53, 33\u201342 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"771_CR131","first-page":"205","volume":"32","author":"M Olmedo","year":"2019","unstructured":"Olmedo, M. et al. Is it reasonable to perform fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with liver cirrhosis? Rev. Esp. Quimioter. 32, 205\u2013207 (2019).","journal-title":"Rev. Esp. Quimioter."},{"key":"771_CR132","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12664-018-0906-1","volume":"37","author":"R Mehta","year":"2018","unstructured":"Mehta, R. et al. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy \u2013 a case series. Indian J. Gastroenterol. 37, 559\u2013562 (2018).","journal-title":"Indian J. Gastroenterol."},{"key":"771_CR133","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp, Z. et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N. Engl. J. Med. 381, 2043\u20132050 (2019).","journal-title":"N. Engl. J. Med."},{"key":"771_CR134","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2050640620967898","volume":"9","author":"JJ Keller","year":"2021","unstructured":"Keller, J. J. et al. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United Eur. Gastroenterol. J. 9, 229\u2013247 (2021).","journal-title":"United Eur. Gastroenterol. J."},{"key":"771_CR135","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000223","volume":"11","author":"MM Mucke","year":"2020","unstructured":"Mucke, M. M. et al. Efficacy of norfloxacin prophylaxis to prevent spontaneous bacterial peritonitis: a systematic review and meta-analysis. Clin. Transl Gastroenterol. 11, e00223 (2020).","journal-title":"Clin. Transl Gastroenterol."},{"key":"771_CR136","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/apt.14361","volume":"46","author":"A Goel","year":"2017","unstructured":"Goel, A., Rahim, U., Nguyen, L. H., Stave, C. & Nguyen, M. H. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis. Aliment. Pharmacol. Ther. 46, 1029\u20131036 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"771_CR137","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass, N. M. et al. Rifaximin treatment in hepatic encephalopathy. N. Engl. J. Med. 362, 1071\u20131081 (2010).","journal-title":"N. Engl. J. Med."},{"key":"771_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.44","volume":"7","author":"DJ Kang","year":"2016","unstructured":"Kang, D. J. et al. Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition. Clin. Transl Gastroenterol. 7, e187 (2016).","journal-title":"Clin. Transl Gastroenterol."},{"key":"771_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060042","volume":"8","author":"JS Bajaj","year":"2013","unstructured":"Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8, e60042 (2013).","journal-title":"PLoS ONE"},{"key":"771_CR140","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","volume":"76","author":"VC Patel","year":"2022","unstructured":"Patel, V. C. et al. Rifaximin-\u03b1 reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. J. Hepatol. 76, 332\u2013342 (2022).","journal-title":"J. Hepatol."},{"key":"771_CR141","first-page":"CD008716","volume":"2","author":"R Dalal","year":"2017","unstructured":"Dalal, R., McGee, R. G., Riordan, S. M. & Webster, A. C. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst. Rev. 2, CD008716 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"771_CR142","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","volume":"64","author":"L Liu","year":"2019","unstructured":"Liu, L., Li, P., Liu, Y. & Zhang, Y. Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis. Dig. Dis. Sci. 64, 3402\u20133412 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"771_CR143","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096\u20131103 (2019).","journal-title":"Nat. Med."},{"key":"771_CR144","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.1096\/fj.201901327R","volume":"33","author":"O Juanola","year":"2019","unstructured":"Juanola, O. et al. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis. FASEB J. 33, 11595\u201311605 (2019).","journal-title":"FASEB J."},{"key":"771_CR145","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/liv.14106","volume":"39","author":"M Jin","year":"2019","unstructured":"Jin, M. et al. Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids. Liver Int. 39, 1437\u20131447 (2019).","journal-title":"Liver Int."},{"key":"771_CR146","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hep.31178","volume":"72","author":"E Smirnova","year":"2020","unstructured":"Smirnova, E. et al. Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity. Hepatology 72, 271\u2013286 (2020).","journal-title":"Hepatology"},{"key":"771_CR147","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/nu11010097","volume":"11","author":"S Roychowdhury","year":"2019","unstructured":"Roychowdhury, S., Glueck, B., Han, Y., Mohammad, M. A. & Cresci, G. A. M. A designer synbiotic attenuates chronic-binge ethanol-induced gut\u2013liver injury in mice. Nutrients 11, 97 (2019).","journal-title":"Nutrients"},{"key":"771_CR148","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jgh.13731","volume":"32","author":"GA Cresci","year":"2017","unstructured":"Cresci, G. A. et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J. Gastroenterol. Hepatol. 32, 1587\u20131597 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"771_CR149","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4983","volume":"243","author":"L Sheng","year":"2017","unstructured":"Sheng, L. et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J. Pathol. 243, 431\u2013441 (2017).","journal-title":"J. Pathol."},{"key":"771_CR150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020868118","volume":"118","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proc. Natl Acad. Sci. USA 118, e2020868118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR151","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx, T. et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut 68, 1504\u20131515 (2019).","journal-title":"Gut"},{"key":"771_CR152","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","volume":"69","author":"K Brandl","year":"2018","unstructured":"Brandl, K. et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J. Hepatol. 69, 396\u2013405 (2018).","journal-title":"J. Hepatol."},{"key":"771_CR153","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0022-4731(90)90182-R","volume":"36","author":"M Axelson","year":"1990","unstructured":"Axelson, M. & Sjovall, J. Potential bile acid precursors in plasma \u2013 possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J. Steroid Biochem. 36, 631\u2013640 (1990).","journal-title":"J. Steroid Biochem."},{"key":"771_CR154","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/hep.1840010210","volume":"1","author":"ZR Vlahcevic","year":"1981","unstructured":"Vlahcevic, Z. R., Goldman, M., Schwartz, C. C., Gustafsson, J. & Swell, L. Bile acid metabolism in cirrhosis. VII. Evidence for defective feedback control of bile acid synthesis. Hepatology 1, 146\u2013150 (1981).","journal-title":"Hepatology"},{"key":"771_CR155","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/0016-5085(81)90253-5","volume":"80","author":"M Ponz de Leon","year":"1981","unstructured":"Ponz de Leon, M., Loria, P., Iori, R. & Carulli, N. Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. Gastroenterology 80, 1428\u20131437 (1981).","journal-title":"Gastroenterology"},{"key":"771_CR156","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949\u2013955 (2013).","journal-title":"J. Hepatol."},{"key":"771_CR157","doi-asserted-by":"publisher","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","volume":"306","author":"G Kakiyama","year":"2014","unstructured":"Kakiyama, G. et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G929\u2013G937 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"771_CR158","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.gastro.2015.05.043","volume":"149","author":"WE Naugler","year":"2015","unstructured":"Naugler, W. E. et al. Fibroblast growth factor signaling controls liver size in mice with humanized livers. Gastroenterology 149, 728\u2013740.e15 (2015).","journal-title":"Gastroenterology"},{"key":"771_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178580","volume":"12","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis. PLoS ONE 12, e0178580 (2017).","journal-title":"PLoS ONE"},{"key":"771_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/srep13462","volume":"5","author":"E Wunsch","year":"2015","unstructured":"Wunsch, E. et al. Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease. Sci. Rep. 5, 13462 (2015).","journal-title":"Sci. Rep."},{"key":"771_CR161","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","volume":"3","author":"KM Schneider","year":"2021","unstructured":"Schneider, K. M. et al. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nat. Metab. 3, 1228\u20131241 (2021).","journal-title":"Nat. Metab."},{"key":"771_CR162","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","volume":"15","author":"HK Min","year":"2012","unstructured":"Min, H. K. et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15, 665\u2013674 (2012).","journal-title":"Cell Metab."},{"key":"771_CR163","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","volume":"67","author":"N Jiao","year":"2018","unstructured":"Jiao, N. et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut 67, 1881\u20131891 (2018).","journal-title":"Gut"},{"key":"771_CR164","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2019.02.048","volume":"157","author":"ER McGlone","year":"2019","unstructured":"McGlone, E. R., Tan, T., Bloom, S. R. & Walters, J. R. F. What can we learn from mouse models about bile acid-mediated changes after bariatric surgery? Gastroenterology 157, 4\u20138 (2019).","journal-title":"Gastroenterology"},{"key":"771_CR165","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/jat.3644","volume":"38","author":"R Thakare","year":"2018","unstructured":"Thakare, R., Alamoudi, J. A., Gautam, N., Rodrigues, A. D. & Alnouti, Y. Species differences in bile acids I. Plasma and urine bile acid composition. J. Appl. Toxicol. 38, 1323\u20131335 (2018).","journal-title":"J. Appl. Toxicol."},{"key":"771_CR166","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","volume":"159","author":"AF Hofmann","year":"1999","unstructured":"Hofmann, A. F. The continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 159, 2647\u20132658 (1999).","journal-title":"Arch. Intern. Med."},{"key":"771_CR167","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1194\/jlr.RA119000243","volume":"61","author":"JF de Boer","year":"2020","unstructured":"de Boer, J. F. et al. A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice. J. Lipid Res. 61, 291\u2013305 (2020).","journal-title":"J. Lipid Res."},{"key":"771_CR168","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/apt.16602","volume":"54","author":"B Simbrunner","year":"2021","unstructured":"Simbrunner, B., Trauner, M. & Reiberger, T. Review article: therapeutic aspects of bile acid signalling in the gut\u2013liver axis. Aliment. Pharmacol. Ther. 54, 1243\u20131262 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"771_CR169","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/13543784.2020.1763302","volume":"29","author":"S Fiorucci","year":"2020","unstructured":"Fiorucci, S., Biagioli, M., Sepe, V., Zampella, A. & Distrutti, E. Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH). Expert Opin. Investig. Drugs 29, 623\u2013632 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"771_CR170","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens, F. et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N. Engl. J. Med. 375, 631\u2013643 (2016).","journal-title":"N. Engl. J. Med."},{"key":"771_CR171","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1080\/14656566.2022.2112945","volume":"23","author":"O Esan","year":"2022","unstructured":"Esan, O., Viljoen, A. & Wierzbicki, A. S. Colesevelam \u2013 a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia. Expert Opin. Pharmacother. 23, 1363\u20131370 (2022).","journal-title":"Expert Opin. Pharmacother."},{"key":"771_CR172","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","volume":"7","author":"RJ Thompson","year":"2022","unstructured":"Thompson, R. J. et al. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol. Hepatol. 7, 830\u2013842 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"771_CR173","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","volume":"391","author":"SA Harrison","year":"2018","unstructured":"Harrison, S. A. et al. NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 391, 1174\u20131185 (2018).","journal-title":"Lancet"},{"key":"771_CR174","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/hep.30590","volume":"71","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis. Hepatology 71, 1198\u20131212 (2020).","journal-title":"Hepatology"},{"key":"771_CR175","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2020.08.004","volume":"160","author":"SA Harrison","year":"2021","unstructured":"Harrison, S. A. et al. Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis. Gastroenterology 160, 219\u2013231.e1 (2021).","journal-title":"Gastroenterology"},{"key":"771_CR176","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S2468-1253(22)00017-6","volume":"7","author":"SA Harrison","year":"2022","unstructured":"Harrison, S. A. et al. Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2\/3): a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Gastroenterol. Hepatol. 7, 603\u2013616 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"771_CR177","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394, 2184\u20132196 (2019).","journal-title":"Lancet"},{"key":"771_CR178","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jhep.2015.12.010","volume":"64","author":"M Ubeda","year":"2016","unstructured":"Ubeda, M. et al. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats. J. Hepatol. 64, 1049\u20131057 (2016).","journal-title":"J. Hepatol."},{"key":"771_CR179","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","volume":"25","author":"H Hao","year":"2017","unstructured":"Hao, H. et al. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis. Cell Metab. 25, 856\u2013867.e5 (2017).","journal-title":"Cell Metab."},{"key":"771_CR180","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep4.1720","volume":"5","author":"BV John","year":"2021","unstructured":"John, B. V. et al. Impact of obeticholic acid exposure on decompensation and mortality in primary biliary cholangitis and cirrhosis. Hepatol. Commun. 5, 1426\u20131436 (2021).","journal-title":"Hepatol. Commun."},{"key":"771_CR181","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504\u2013516 (2012).","journal-title":"Cancer Cell"},{"key":"771_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31312-5","volume":"13","author":"KM Schneider","year":"2022","unstructured":"Schneider, K. M. et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat. Commun. 13, 3964 (2022).","journal-title":"Nat. Commun."},{"key":"771_CR183","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97\u2013101 (2013).","journal-title":"Nature"},{"key":"771_CR184","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70, 761\u2013774 (2021).","journal-title":"Gut"},{"key":"771_CR185","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","volume":"175","author":"V Singh","year":"2018","unstructured":"Singh, V. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175, 679\u2013694.e22 (2018).","journal-title":"Cell"},{"key":"771_CR186","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma, C. et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360, eaan5931 (2018).","journal-title":"Science"},{"key":"771_CR187","first-page":"E1306","volume":"113","author":"J Li","year":"2016","unstructured":"Li, J. et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc. Natl Acad. Sci. USA 113, E1306\u2013E1315 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR188","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani, F. R. et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69, 107\u2013120 (2019).","journal-title":"Hepatology"},{"key":"771_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20422-7","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary, J. et al. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat. Commun. 12, 187 (2021).","journal-title":"Nat. Commun."},{"key":"771_CR190","doi-asserted-by":"publisher","first-page":"G1319","DOI":"10.1152\/ajpgi.00140.2010","volume":"299","author":"GL Su","year":"2010","unstructured":"Su, G. L., Hoesel, L. M., Bayliss, J., Hemmila, M. R. & Wang, S. C. Lipopolysaccharide binding protein inhibitory peptide protects against acetaminophen-induced hepatotoxicity. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1319\u2013G1325 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"771_CR191","doi-asserted-by":"publisher","first-page":"688780","DOI":"10.3389\/fphys.2021.688780","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen, T., Li, R. & Chen, P. Gut microbiota and chemical-induced acute liver injury. Front. Physiol. 12, 688780 (2021).","journal-title":"Front. Physiol."},{"key":"771_CR192","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jcmgh.2020.11.002","volume":"11","author":"KM Schneider","year":"2021","unstructured":"Schneider, K. M. et al. Intestinal dysbiosis amplifies acetaminophen-induced acute liver injury. Cell Mol. Gastroenterol. Hepatol. 11, 909\u2013933 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"771_CR193","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.29327","volume":"67","author":"LY Yip","year":"2018","unstructured":"Yip, L. Y. et al. The liver\u2013gut microbiota axis modulates hepatotoxicity of tacrine in the rat. Hepatology 67, 282\u2013295 (2018).","journal-title":"Hepatology"},{"key":"771_CR194","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1073\/pnas.0904489106","volume":"106","author":"TA Clayton","year":"2009","unstructured":"Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant host\u2013microbiome metabolic interaction affecting human drug metabolism. Proc. Natl Acad. Sci. USA 106, 14728\u201314733 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR195","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1073\/pnas.1424775112","volume":"112","author":"HH Chou","year":"2015","unstructured":"Chou, H. H. et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc. Natl Acad. Sci. USA 112, 2175\u20132180 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"771_CR196","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3389\/fimmu.2019.00927","volume":"10","author":"T Wu","year":"2019","unstructured":"Wu, T. et al. CD4+ T cells play a critical role in microbiota-maintained anti-HBV immunity in a mouse model. Front. Immunol. 10, 927 (2019).","journal-title":"Front. Immunol."},{"key":"771_CR197","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","volume":"141","author":"NG Sandler","year":"2011","unstructured":"Sandler, N. G. et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141, 1220\u20131230 (2011).","journal-title":"Gastroenterology"},{"key":"771_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01273-y","author":"RO Ali","year":"2022","unstructured":"Ali, R. O. et al. Longitudinal multi-omics analyses of the gut\u2013liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-022-01273-y (2022).","journal-title":"Nat. Microbiol."},{"key":"771_CR199","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/apt.15004","volume":"48","author":"FR Ponziani","year":"2018","unstructured":"Ponziani, F. R. et al. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment. Pharmacol. Ther. 48, 1301\u20131311 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"771_CR200","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh, T. G. et al. A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab. 32, 878\u2013888.e6 (2020).","journal-title":"Cell Metab."},{"key":"771_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31654-0","volume":"13","author":"O Mzava","year":"2022","unstructured":"Mzava, O. et al. A metagenomic DNA sequencing assay that is robust against environmental DNA contamination. Nat. Commun. 13, 4197 (2022).","journal-title":"Nat. Commun."},{"key":"771_CR202","doi-asserted-by":"publisher","first-page":"2104086","DOI":"10.1080\/19490976.2022.2104086","volume":"14","author":"G Han","year":"2022","unstructured":"Han, G., Luong, H. & Vaishnava, S. Low abundance members of the gut microbiome exhibit high immunogenicity. Gut Microbes 14, 2104086 (2022).","journal-title":"Gut Microbes"},{"key":"771_CR203","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"Le Roy, T. et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62, 1787\u20131794 (2013).","journal-title":"Gut"},{"key":"771_CR204","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"},{"key":"771_CR205","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","volume":"180","author":"J Walter","year":"2020","unstructured":"Walter, J., Armet, A. M., Finlay, B. B. & Shanahan, F. Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell 180, 221\u2013232 (2020).","journal-title":"Cell"},{"key":"771_CR206","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-019-0667-z","volume":"17","author":"AM Thomas","year":"2019","unstructured":"Thomas, A. M. & Segata, N. Multiple levels of the unknown in microbiome research. BMC Biol. 17, 48 (2019).","journal-title":"BMC Biol."},{"key":"771_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23460-x","volume":"12","author":"D van der Lelie","year":"2021","unstructured":"van der Lelie, D. et al. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. Nat. Commun. 12, 3105 (2021).","journal-title":"Nat. Commun."},{"key":"771_CR208","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mib.2021.08.004","volume":"63","author":"BM Miller","year":"2021","unstructured":"Miller, B. M., Liou, M. J., Lee, J. Y. & Baumler, A. J. The longitudinal and cross-sectional heterogeneity of the intestinal microbiota. Curr. Opin. Microbiol. 63, 221\u2013230 (2021).","journal-title":"Curr. Opin. Microbiol."},{"key":"771_CR209","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"771_CR210","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10062","volume":"6","author":"TP Bui","year":"2015","unstructured":"Bui, T. P. et al. Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat. Commun. 6, 10062 (2015).","journal-title":"Nat. Commun."},{"key":"771_CR211","doi-asserted-by":"publisher","first-page":"eabp9960","DOI":"10.1126\/science.abp9960","volume":"377","author":"JY Lee","year":"2022","unstructured":"Lee, J. Y., Tsolis, R. M. & Baumler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).","journal-title":"Science"},{"key":"771_CR212","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577\u2013591 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"771_CR213","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","volume":"579","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature 579, 586\u2013591 (2020).","journal-title":"Nature"},{"key":"771_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05767-4","volume":"9","author":"A Kindt","year":"2018","unstructured":"Kindt, A. et al. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nat. Commun. 9, 3760 (2018).","journal-title":"Nat. Commun."},{"key":"771_CR215","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"771_CR216","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha, A. et al. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180, 1067\u20131080.e16 (2020).","journal-title":"Cell"},{"key":"771_CR217","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino, A., Demagny, H., Velazquez-Villegas, L. & Schoonjans, K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol. Rev. 101, 683\u2013731 (2021).","journal-title":"Physiol. Rev."},{"key":"771_CR218","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22\u201339 (2016).","journal-title":"Gut Microbes"},{"key":"771_CR219","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1194\/jlr.RA120001021","volume":"61","author":"S Marion","year":"2020","unstructured":"Marion, S. et al. Biogeography of microbial bile acid transformations along the murine gut. J. Lipid Res. 61, 1450\u20131463 (2020).","journal-title":"J. Lipid Res."},{"key":"771_CR220","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432\u2013450 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"771_CR221","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/164_2019_230","volume":"256","author":"V Keitel","year":"2019","unstructured":"Keitel, V., Stindt, J. & Haussinger, D. Bile acid-activated receptors: GPBAR1 (TGR5) and other G protein-coupled receptors. Handb. Exp. Pharmacol. 256, 19\u201349 (2019).","journal-title":"Handb. Exp. Pharmacol."},{"key":"771_CR222","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcmgh.2021.01.011","volume":"12","author":"J Leonhardt","year":"2021","unstructured":"Leonhardt, J. et al. Circulating bile acids in liver failure activate TGR5 and induce monocyte dysfunction. Cell Mol. Gastroenterol. Hepatol. 12, 25\u201340 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"771_CR223","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2014","unstructured":"Schaap, F. G., Trauner, M. & Jansen, P. L. Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 11, 55\u201367 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00771-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00771-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00771-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:23:13Z","timestamp":1702254193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00771-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":223,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1038\/s41575-023-00771-6","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"23 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}